• Blog
  • Canine Flu Therapeutics Market Report

    Canine Flu Therapeutics Market Report

    Canine Flu Therapeutics Market Report
    Report code - SRHL323 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Canine Flu Therapeutics Market, Dynamics, Trends, Market Analysis
    See more...

    Impact of COVID-19 on Canine Flu Therapeutics Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Canine Flu Therapeutics Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Canine Flu Therapeutics Market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of over xx% during the forecast period.

    Figure: Global Canine Flu Therapeutics Market Size, 2020-2026 (USD Billion)

    Wish to get a free sample report on this study? Click here.

    What are Canine Flu Therapeutics?

    Canine flu also referred to as dog flu, is a contagious disease that affects the dog’s respiratory system. It is primarily caused by the canine influenza virus or type A influenza virus. The flu consists of two types of influenza viruses H3N8 and the H3N2 virus. The symptoms of this disease include reduced appetite, upper respiratory illness, cough, eye discharges, runny nose, fever, and lethargy. The severity of the flu can range from dogs with no symptoms to terminal illness which can lead to pneumonia and finally death.

    Key Players

    Key players operating in the global canine flu therapeutics market are-

    • Merck Animal Health (The US),
    • GlaxoSmithKline (UK),
    • Pfizer (The U.S),
    • Zoetis (The U.S),
    • Novartis (Switzerland),
    • Sanofi (France),
    • Boehringer Ingelheim International (Germany),
    • Bristol-Myers Squibb (The U.S),
    • Roche (Switzerland),
    • Eli Lilly and Company (The U.S), and
    • Abbott Laboratories (The U.S).

    Market Dynamics

    Dogs are highly vulnerable to canine flu if they come in contact with the respiratory flow/discharges of the infected canines. As per the study by the Wisconsin University, the H3N2 virus retains its existence for a longer period of time when compared to the H3N8 virus, which leads to the spread of canine flu in other dogs resulting in multiple outbreaks. Dogs with canine flu cannot be easily identified, and so these dogs need protection. Moreover, there is no specific treatment for the disease thus stresses on the veterinary society to discover new drugs, which in turn augments the product demand.

    Segment Analysis

    Type Trends

    By type, the canine flu therapeutics market has been segmented into vaccines, antibiotics, anti-inflammatory drugs, and others. Under these, the vaccines segment accounted for the largest market share in 2020 and is projected to register a healthy CAGR in the following years. Vaccination against canine flu influenza can significantly reduce the risk of the dog contracting the canine influenza virus, thus reduces the exposure, which bolsters the segment growth.

    Regional Trends

    By region, the market in North America garnered the highest market share in 2020 and is projected to grow at a steady CAGR during the assessment period. This is mainly attributed to improvisation and development in the sex toys and condoms, rising LGBTQ+ population, increasing awareness of STDs and HIV infections, and increasing liberalization and experimentation of sexuality among the people, which further augments the regional growth.

    North America dominant in the Global canine flu therapeutic market mainly due to the high penetration. In North America, particularly the USA is dominating due to the high adoption of treatment method to the canine flu.

    COVID-19 Impact on Global Canine Flu Therapeutics Market

    The COVID-19 pandemic has positively influenced the Canine Flu Therapeutics industry. Condoms have experienced a surge, whereas the demand for sex toys and other items witnessed a temporary decline. However, to attend to their sexual needs due to the limited movement of people with partners staying in different homes, people have started relying on vibrators and other sex toys to cater to their sexual pleasure. Governments around the world have issued advisories to encourage safe sex with partners during the lockdown.

    Critical Questions Answered in the Report

    • What are the key trends in the global Canine Flu Therapeutics market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global Canine Flu Therapeutics market?
    • What are the key strategies adopted by the major vendors to lead in the global Canine Flu Therapeutics market?
    • What is the market share of the top vendors?

    Wish to know more about the study? Click here.

    Target Audience

    • Canine Flu Therapeutics companies
    • Canine Flu Therapeutics vendors
    • Condom companies
    • STD awareness organizations
    • LGBTQ communities

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Merck Animal Health (The US), GlaxoSmithKline (UK), Pfizer (The U.S), Zoetis (The U.S), Novartis (Switzerland), Sanofi (France), Boehringer Ingelheim International (Germany), Bristol-Myers Squibb (The U.S), Roche (Switzerland), Eli Lilly and Company (The U.S) and Abbott Laboratories (The U.S) are among the key players in the canine flu therapeutics market.

    North America garnered the highest market share in 2020 and is projected to grow at a steady CAGR.

    The vaccines segment accounted for the largest market share in 2020 and is projected to register a healthy CAGR.

    Canine Flu Therapeutics companies, Canine Flu Therapeutics vendors, Condom companies, STD awareness organizations, LGBTQ communities are the target audience in the canine flu therapeutics market.

    •